Osteopore Limited (ASX:OSX)

Market Cap	2.60M
Revenue (ttm)	2.76M
Net Income (ttm)	-3.35M
Shares Out	173.43M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	153,685
Average Volume	2,203,377
Open	0.0140
Previous Close	0.0150
Day's Range	0.0140 - 0.0140
52-Week Range	0.0120 - 0.1000
Beta	-0.28
RSI	43.63
Earnings Date	May 30, 2025

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, the United States, Malaysia, Indonesia, Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2024, Osteopore's revenue was 2.76 million, an increase of 24.60% compared to the previous year's 2.22 million. Losses were -3.35 million, -31.19% less than in 2023.